Advances in Pseudoprogression of Immune Checkpoint Inhibitors 
in Non-small Cell Lung Cancer

The advent of immune checkpoint inhibitors (ICIs) has greatly improved the prognosis of advanced lung cancer patients, but can lead to pseudoprogression (PsP), which complicates clinical evaluation and management. PsP is manifested as temporary enlargement of the tumour or the appearance of new lesi...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Yajun TONG, Yong LONG, Fan ZHANG, Junfeng LI
Format:	Artigo
Sprache:	Chinês
Veröffentlicht:	Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2024-04-01
Schriftenreihe:	Chinese Journal of Lung Cancer
Schlagworte:	lung neoplasms immune checkpoint inhibitors pseudoprogression immunotherapy
Online-Zugang:	http://dx.doi.org/10.3779/j.issn.1009-3419.2024.101.10
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!